Suchergebnisse - "Heijns, Joan B"

PubPharm (47)

1

MRI-guided optimisation of neoadjuvant chemotherapy duration in stage II-III HER2-positive breast cancer (TRAIN-3) : a multicentre, single-arm, phase 2 study

enthalten in: The Lancet. Oncology | 2024

von van der Voort, A. | Louis, F. | van Ramshorst, M. | +52

2

Time trends in real-world treatment patterns and survival in patients diagnosed with de novo HER2+ metastatic breast cancer : an analysis of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2024

von Geurts, S. | Ibragimova, K. | Ding, N. | +16

3

Trastuzumab Resistance in Patients With HER2-Positive Advanced Breast Cancer : Results From the SONABRE Registry

enthalten in: Clinical breast cancer | 2024

von Ibragimova, K. | Geurts, S. | Laczkó, D. | +14

4

The prognostic impact of BMI in patients with HR+/HER2- advanced breast cancer : a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2024

von Lammers, S. | Thurisch, H. | Vriens, I. | +15

5

Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival

enthalten in: NPJ breast cancer | 2023

von Verschoor, N. | de Weerd, V. | Van, M. | +10

6

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer : results from the SONABRE registry

enthalten in: Breast cancer research and treatment | 2023

von Ibragimova, K. | Geurts, S. | Meegdes, M. | +12

7

Real-world time trends in overall survival, treatments and patient characteristics in HR+/HER2- metastatic breast cancer : an observational study of the SONABRE Registry

enthalten in: The Lancet regional health. Europe | 2023

von Meegdes, M. | Geurts, S. | Erdkamp, F. | +12

8

Outcomes for the first four lines of therapy in patients with HER2-positive advanced breast cancer: results from the SONABRE registry

enthalten in: Breast cancer research and treatment | 2023

von Ibragimova, K. | Geurts, S. | Meegdes, M. | +12

9

Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer

enthalten in: JAMA network open | 2022

von Owusuaa, C. | van der Padt-Pruijsten, A. | Drooger, J. | +7

10

The initial hormone receptor/HER2 subtype is the main determinator of subtype discordance in advanced breast cancer : a study of the SONABRE registry

enthalten in: Breast cancer research and treatment | 2022

von Meegdes, M. | Ibragimova, K. | Lobbezoo, D. | +16

1
2
3
4
5
Nächster »
[5]